Patent details

EP4176048 Title: GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP4176048
WO Application Number:
IB2021058704
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP21787042.7
WO Publication Number:
WO2022064428
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
23/09/2021
Grant date:
11/09/2024
EP Publication Date:
10/05/2023
WO Publication Date:
31/03/2022
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/09/2024
EP B1 Publication Date:
11/09/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
22/09/2041
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
11/09/2024
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/09/2024
 
 

 

Name:
CRISPR Therapeutics AG
Address:
Baarerstrasse 14, 6300 Zug, Switzerland (CH)

Inventor

1

Name:
DEQUEANT, Mary-Lee
Address:
Cambridge, Massachusetts 02139, United States of America (US)

2

Name:
KALAITZIDIS, Demetrios
Address:
Cambridge, Massachusetts 02139, United States of America (US)

3

Name:
GHONIME, Mohammed
Address:
Cambridge, Massachusetts 02139, United States of America (US)

Priority

1

Priority Patent Number:
202163225673 P
Priority Date:
26/07/2021
Priority Country:
United States of America (US)

2

Priority Patent Number:
202063124429 P
Priority Date:
11/12/2020
Priority Country:
United States of America (US)

3

Priority Patent Number:
202063082357 P
Priority Date:
23/09/2020
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 39/00; C12N 5/0783; A61K 35/17; A61K 38/00; C12N 15/113; C12N 15/90; A61K 48/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
03/25
Publication date:
15/01/2025
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
37/24
Publication date:
11/09/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202437
Publication date:
11/09/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type